معرفی
Alfonso Aixa, PhD, is an Associate Professor and Director of Undergraduate Studies in the Department of Biological Sciences at the University of Illinois Chicago (UIC), within the College of Liberal Arts and Sciences. His research focuses on understanding neuronal polarity and the molecular mechanisms governing synaptic vesicle trafficking and neuronal differentiation using the model organism Caenorhabditis elegans (C. elegans). He holds a BS from the University of Puerto Rico-Rio Piedras and a PhD from the University of Wisconsin-Madison.
Dr. Aixa’s research has two primary areas: (1) the role of the clathrin adaptor protein UNC-11/AP180 in synaptic vesicle protein sorting and trafficking, and (2) the function of HLH-3, a basic helix-loop-helix transcription factor critical for sex-specific neuronal differentiation in C. elegans. His work bridges cell biology and developmental biology, with implications for understanding fundamental membrane trafficking processes and neurodevelopmental disorders.
His publications span molecular mechanisms of synaptic vesicle biogenesis, neuronal circuitry development, and genetic modifiers of neurodegenerative processes. He has contributed to studies on α-synuclein, parkin, and DJ-1 in C. elegans models, linking these findings to mitochondrial dysfunction and Parkinson’s disease pathways. His lab’s findings on UNC-11 and HLH-3 have advanced understanding of clathrin-mediated endocytosis and transcriptional regulation of neuronal identity.
Dr. Aixa’s academic leadership includes directing undergraduate studies in Biological Sciences at UIC, emphasizing student mentorship and curriculum development in life sciences. His research has been supported by grants focusing on C. elegans genetics and neuronal mechanisms, though specific grant details are not provided in the text.
Key collaborations include work with institutions like UI Health and international teams studying molecular pathways in neurobiology. His lab’s future directions aim to further characterize HLH-3’s downstream targets and explore therapeutic applications of C. elegans models in neurodegenerative research.
